Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 75.19M P/E - EPS this Y 55.00% Ern Qtrly Grth -
Income -12.75M Forward P/E -3.33 EPS next Y -22.20% 50D Avg Chg -25.00%
Sales - PEG - EPS past 5Y - 200D Avg Chg -24.00%
Dividend N/A Price/Book N/A EPS next 5Y - 52W High Chg -63.00%
Recommedations 1.50 Quick Ratio 0.46 Shares Outstanding 5.32M 52W Low Chg 59.00%
Insider Own - ROA -178.20% Shares Float 4.27M Beta 0.34
Inst Own - ROE - Shares Shorted/Prior 93.27K/107.86K Price 1.73
Gross Margin - Profit Margin - Avg. Volume 229,796 Target Price 51.90
Oper. Margin - Earnings Date Nov 5 Volume 85,316 Change -0.57%
About Brainstorm Cell Therapeutics In

Brainstorm Cell Therapeutics Inc., a biotechnology company, engages in the development and commercialization of autologous cellular therapies for the treatment of neurodegenerative diseases. The company, through its NurOwn proprietary cell therapy platform, leverages cell culture methods to induce autologous bone marrow-derived mesenchymal stem cells to secrete high levels of neurotrophic factors, modulate neuroinflammatory and neurodegenerative disease processes, promote neuronal survival, and enhance neurological function. It is developing NurOwn, which has completed Phase III clinical trial for the treatment of amyotrophic lateral sclerosis; Phase II clinical trial for the treatment of progressive multiple sclerosis; and for the treatment of alzheimer's disease, as well as for other neurodegenerative diseases. Brainstorm Cell Therapeutics Inc. was incorporated in 2000 and is headquartered in New York, New York.

Brainstorm Cell Therapeutics In News
11/14/24 BrainStorm Cell Therapeutics Announces Third Quarter 2024 Financial Results and Provides Corporate Update
11/11/24 BrainStorm Cell Therapeutics and Pluri Partner to Support NurOwn® Phase 3b Trial Manufacturing
10/30/24 BrainStorm Cell Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Requirement
10/28/24 BrainStorm Cell Therapeutics Presented Positive Survival Data from NurOwn® Expanded Access Program at 2024 Annual NEALS Meeting
10/07/24 BrainStorm Cell Therapeutics to Provide Corporate Update on Phase 3b NurOwn® Trial at the 2024 Maxim Healthcare Virtual Summit
09/24/24 BrainStorm Cell Therapeutics Announces Presentations on NurOwn® at 2024 Annual NEALS Meeting
09/16/24 Life Sciences Virtual Investor Forum Agenda Announced for September 19th
08/19/24 BCLI: SPA in Place for Phase 3b Trial of NurOwn® in ALS…
08/14/24 BrainStorm Cell Therapeutics Announces Second Quarter 2024 Financial Results and Provides Corporate Update
08/07/24 BrainStorm Cell Therapeutics to Announce Second Quarter Results and Provide a Corporate Update
07/24/24 BCLI Update - Progress Supports Our 10x Plus Value Range Potential
07/10/24 BCLI: Preparing to Initiate Phase 3b Trial of NurOwn™ Before End of 2024…
07/01/24 BrainStorm Cell Therapeutics to Provide Corporate Mid-Year Update on NurOwn Program
06/27/24 BrainStorm Cell Therapeutics Announces Pricing of $4.0 Million Registered Direct Offering
06/26/24 BrainStorm Cell Therapeutics Reaches Alignment with FDA on CMC Aspects of Phase 3b NurOwn® Clinical Trial
06/20/24 BrainStorm Cell Therapeutics Announces Appointment of Haro Hartounian Ph.D. as Chief Operating Officer
06/14/24 BCLI: Initiation - Potential 10x Return on Successful Phase 3b. Promising Post Hoc and Biomarker Analysis Underpins Our NurOwn® Clinical Effectiveness Expectation
05/20/24 BrainStorm Cell Therapeutics to Present New Biomarker Data Suggesting ALS Patients May Benefit From Longer-Term Treatment with NurOwn
05/14/24 BrainStorm Cell Therapeutics Announces First Quarter 2024 Financial Results and Provides Corporate Update
04/16/24 BrainStorm Cell Therapeutics Announces Management Changes as Company Plans Registrational Phase 3b Trial of NurOwn
BCLI Chatroom

User Image TradersTrader Posted - 3 hours ago

$TSOI $NWBO $BCLI After civil issues are resolved, how soon might we see criminal charges filed against these perpetrators and their puppet masters?? Will SDSC refer to prosecutors in CA? PS. How many other companies have been wronged by this group and groups like them? Is there SM site collusion? HF’s? VC’s? Open question to all real investors tired of being manipulated. Share your thoughts!

User Image Pipemajors82 Posted - 9 hours ago

$BCLI https://www.facebook.com/share/p/htcvNWNS7SHSNfJY/

User Image Pipemajors82 Posted - 12 hours ago

$BCLI https://www.facebook.com/share/cvhHmbbzzpbaJoxX/

User Image HUMBL4Now Posted - 15 hours ago

$BCLI what do we think of the new FDA commissioner?

User Image afc2881 Posted - 1 day ago

$BCLI This is forming a base here A great opportunity to join/add shares. This company will revolutionize als treatment forever. Go Nurown Save Lives

User Image TradersTrader Posted - 1 day ago

If it wasn’t for $TSOI , I wouldn’t know about the good work being done by $NWBO and $BCLI And the many Drs./PhDs/Inventors that sacrifice much for the betterment of all. And visa versa. We are many. They are few and trapped in the shadows. Hemmed in by supposed anonymity. Dark hand-in-glove SM confidence scams. The advantage is ours. We exist in the light, where they cannot follow. Remember that.

User Image TradersTrader Posted - 1 day ago

$TSOI $NWBO $BCLI We’re investing in/supporting a future where cancer/disease can be eradicated totally by the root, leveraging God’s brilliant design; Immunology/The Immune System. The days of life-long, perma-patient, half-measure science, is sun setting. A patent cliff approaches. The future of immunological medicine/regenerative medicine is here. Know what you own, and own it!! 👍

User Image thres Posted - 1 day ago

$BCLI Nurown supporters did all the heavy lifting and got ACT for ALS approved off the skin of their backs. Many of the best warriors Died-Waiting and Nurown deniers got all the ACT for ALS funding for the pre-clinical and phase1-2 trials; Nurown Supporters got nothing, they got died-waiting. Not many ALS patients are raving about the new med trial offered through ACT for ALS, for sure many would rather be on Nurown. Start phase 3B trial soonest; first 6 months: 100 patients x 3 injections 100 patients x placebo. 2nd 6 months 200 patients x 3 injections. Nurown must rise again and win the this time. It is time to let the Genie out of the bottle. Go Nurown!!!

User Image TradersTrader Posted - 2 days ago

$TSOI $BCLI $NWBO May God be with all those who fight the good fight to beat, and to find cures, for cancer - and their loving dedicated families/friends ♥️ A wonderfully written book, by a truly amazing woman/mother/wife; Florica Batu Ichim. https://dumitruichim.files.wordpress.com/2011/10/at-the-gates-of-despair-beginning-of-hope1.pdf

User Image Knuckles30 Posted - 3 days ago

$BCLI It held out all day Just sold me 72 shares at 1.25 all day

User Image CousinsCapital Posted - 3 days ago

$BCLI this thing is pinned

User Image Knuckles30 Posted - 3 days ago

$BCLI I'm in at 1.25 10m. Only filled 72 Hope it holds up

User Image zrosiez Posted - 3 days ago

$BCLI I think it’s going to 0.18

User Image TradersTrader Posted - 3 days ago

$TSOI $NWBO $BCLI The cream always rises to the top, my friends. KNOW what you own, and own it!!

User Image funnymoney90210 Posted - 4 days ago

$BCLI

User Image Knuckles30 Posted - 4 days ago

$BCLI Blocking the shorts at 121 for now With a buy ar 1.21. 10,000 shares

User Image donkeydink Posted - 4 days ago

$BCLI short pool almost down to zero. Buying even a few shares over market makes it much harder to walk us down.

User Image thres Posted - 4 days ago

$BCLI ALS patients want Nurown because they know it works. How many ALS meds are actively supported by ALS patients like Nurown is? Let's get Phase 3B started and put drugs in bodies. Go Nurown!!!

User Image Letstreatals Posted - 5 days ago

$BCLI https://endpts.com/fda-offers-more-guidance-on-developing-cell-and-gene-therapies/

User Image HUMBL4Now Posted - 5 days ago

$BCLI keep the momentum going

User Image funnymoney90210 Posted - 6 days ago

$BCLI saving lives! Headed to $5

User Image HUMBL4Now Posted - 1 week ago

$BCLI great day! Happy Friday folks!

User Image MrBULL22 Posted - 1 week ago

$CERO $HIMS $HSCS $BCLI $LUNG

User Image AshvsEvilDead Posted - 1 week ago

$BCLI Vivek. Given this, he is 100% in Brainstorms corner.

User Image Igmon007 Posted - 1 week ago

$BCLI Looks like they burned through the $3 million they raised in one Q and have no $$ left. It also looks like they started ATM'ing from the beginning of Oct to pay for their daily expenses since they had only $350k left on their books on Sept 30th. If you don't get this grant and additional $$ from somewhere we're screwed.

User Image AshvsEvilDead Posted - 1 week ago

$BCLI No better risk ratio out there. If they can achieve anything near 50million in non dilutive funding, you’re looking at a share price near 10/share. With substantial growth following a successful trial (which is already substantially de-risked)

User Image Knuckles30 Posted - 1 week ago

$BCLI Have a decent buy order at 1.08 Keeps hitting 1.08.5. So we know the magic number today Only filled 104 out of 9500

User Image thres Posted - 1 week ago

$BCLI , BrainStorm entered into a Memorandum of Understanding (MOU) with Pluri Inc. (Pluri) to manufacture NurOwn® for use in the planned Phase 3b ALS trial. This MOU enables Brainstorm to begin the immediate transfer of its manufacturing technology and start producing NurOwn at Pluri's facility while the binding definitive agreement is being finalized. Let's get Phase 3B started Go Nurown!!! Let's start producing Nurown again!!!

User Image Davidwxyz Posted - 1 week ago

$BCLI Bought some at $1.13. Looks good for a bounce at least. I imagine this phase 3b als study should be completing sometime in the not too distant future? With the CEO buying shares a while ago and this study on deck an initial run up could get back to $5 plus.

User Image afc2881 Posted - 1 week ago

$BCLI Vivek for Fda Commisioner.

Analyst Ratings
Maxim Group Buy Jul 11, 24
Maxim Group Hold Sep 28, 23
Maxim Group Buy Mar 31, 23
Maxim Group Buy Feb 5, 21
HC Wainwright & Co. Buy May 15, 18
Maxim Group Buy Aug 17, 17